Pramoda Anita 4

Accession 0001562180-21-000395

CIK 0001636422other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 6:08 PM ET

Size

25.5 KB

Accession

0001562180-21-000395

Form 4

Period: 2021-01-15

Director

Transactions

Sale
Common Stock
2021-01-15$48.09/sh−16,500$793,480→ 5,443 total
Exercise/Conversion
Common Stock
2021-01-15$10.40/sh+16,500$171,600→ 39,443 total
Sale
Common Stock
2021-01-15$48.05/sh−8,753$420,551→ 30,690 total
Sale
Common Stock
2021-01-15$48.04/sh−7,500$360,319→ 21,943 total
Exercise/Conversion
Common Stock
2021-01-15$10.66/sh+1,247$13,293→ 6,690 total
Exercise/Conversion
Common Stock
2021-01-15$10.66/sh+8,753$93,307→ 22,943 total
Sale
Common Stock
2021-01-15$48.00/sh−1,247$59,856→ 29,443 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-15−7,500→ 12,500 total
Exercise: $10.66Exp: 2027-04-27→ Common Stock (7,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-15−1,247→ 2,500 total
Exercise: $10.66Exp: 2027-04-27→ Common Stock (1,247 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-15−16,500→ 0 total
Exercise: $10.40Exp: 2026-04-28→ Common Stock (16,500 underlying)
Exercise/Conversion
Common Stock
2021-01-15$10.66/sh+7,500$79,950→ 14,190 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-15−8,753→ 3,747 total
Exercise: $10.66Exp: 2027-04-27→ Common Stock (8,753 underlying)

Footnotes (6)

[F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 14, 2019, in accordance with Rule 10b5-1.
[F2]Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.00 to $48.21, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 - 4.
[F3]Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.00 to $48.18, inclusive.
[F4]Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $48.00 to $48.28, inclusive.
[F5]25% of the 20,000 shares underlying the options vested in an annual installment on April 27, 2018 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on April 27, 2021.
[F6]25% of the 62,500 shares underlying the options vested in an annual installment on April 28, 2017 and the remaining balance vested in equal monthly installments until the option vested in full on April 28, 2020.

Documents

1 file

Health Catalyst, Inc.

CIK 0001636422

Entity typeother